These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2386447)

  • 1. Differential effects of scopolamine and amphetamine on microcomputer-based performance tests.
    Kennedy RS; Odenheimer RC; Baltzley DR; Dunlap WP; Wood CD
    Aviat Space Environ Med; 1990 Jul; 61(7):615-21. PubMed ID: 2386447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of scopolamine and dextroamphetamine on human performance.
    Schmedtje JF; Oman CM; Letz R; Baker EL
    Aviat Space Environ Med; 1988 May; 59(5):407-10. PubMed ID: 3390096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antimotion sickness drug side effects on performance.
    Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
    Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side effects of antimotion sickness drugs.
    Wood CD; Manno JE; Manno BR; Redetzki HM; Wood M; Vekovius WA
    Aviat Space Environ Med; 1984 Feb; 55(2):113-6. PubMed ID: 6696702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
    Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
    Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of antimotion sickness drugs on habituation to motion.
    Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE
    Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A; Knepton J; Shaw J
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
    Graybiel A; Cramer DB; Wood CD
    Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
    Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
    Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transcutaneous scopolamine and depth on diver performance.
    Williams TH; Wilkinson AR; Davis FM; Frampton CM
    Undersea Biomed Res; 1988 Mar; 15(2):89-98. PubMed ID: 3363755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of some motion sickness suppressants on static and dynamic tracking performance.
    Schroeder DJ; Collins WE; Elam GW
    Aviat Space Environ Med; 1985 Apr; 56(4):344-50. PubMed ID: 3994616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
    Lieberman HR; Tharion WJ; Shukitt-Hale B; Speckman KL; Tulley R
    Psychopharmacology (Berl); 2002 Nov; 164(3):250-61. PubMed ID: 12424548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
    Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
    Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
    Wilkinson CJ
    J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: psychometric and psychophysiological evaluation.
    Grünberger J; Saletu B; Linzmayer L; Barbanoj MJ
    Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):313-28. PubMed ID: 8412415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.
    van Ruitenbeek P; Vermeeren A; Riedel W
    J Psychopharmacol; 2008 Aug; 22(6):663-72. PubMed ID: 18208925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.